Advertisement
Sign In
Search
By Debbie Bunch February 19, 2024 Why Premature Lungs are So Stressed German researchers are shedding some light on why mechanical ventilation is especially hard on premature lungs. The investigators, who study the physics of mechanical stress resulting from ventilation at Liepzig University, used lung tissue from fetal and adult rats to determine how varying … Continued
By Debbie Bunch June 16, 2025 Long-Acting Antibody Cuts Bronchiolitis Hospitalizations for Infants Under Six Months of Age European researchers have found that just one dose of a long-acting antibody known as nirsevimab can nearly halve the number of young infants who require hospitalization for bronchiolitis. The finding came from a review of data on children … Continued
By Debbie Bunch Daily Urine Tests May Predict COPD Exacerbations A simple urine test may one day be able to predict a COPD exacerbation, report researchers from the U.K. who published their findings in ERJ Open Research. The investigators began by analyzing urine samples from 55 COPD patients to look for changes in their urine … Continued
COPD Prevalence Remains Flat A study published in the CDC’s Morbidity and Mortality Weekly Report suggests COPD prevalence may have reached a plateau. The investigators arrived at that conclusion after looking at data from the Behavioral Risk Factor Surveillance System, which the CDC defines as “an annual state-based, random-digit-dialed mobile and landline telephone survey among noninstitutionalized U.S. … Continued
By Debbie Bunch July 16, 2024 Primary Care Clinic Improves Care for COPD Patients Chinese researchers publishing in JAMA Health Forum have found that a primary care clinic led by nurses and allied health professionals, including physiotherapists and occupational therapists, can significantly improve care for people with COPD. The investigators compared outcomes among 3093 COPD … Continued
First Biologic for COPD Crosses Another Hurdle According to Sanofi, the biologic drug Dupixent® reduced COPD exacerbations by 34% when compared to placebo in the second of two Phase 3 trials. The NOTUS trial also confirmed that treatment with Dupixent led to rapid and significant improvements in lung function by 12 weeks and that those … Continued
Read the latest studies in respiratory care in this week’s edition of RC Currents. We discuss new tests, lung disease, and more.
Advertisement
